Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide [PDF]
BACKGROUND: The B-type natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (pBNP) are predictors of cardiovascular morbidity and mortality. Since the artificial intelligence (AI)-enabled electrocardiogram (ECG) system is widely used in
Pang-Yen Liu +6 more
doaj +4 more sources
Machine learning‐based prediction of elevated N terminal pro brain natriuretic peptide among US general population [PDF]
Aims Natriuretic peptide‐based pre‐heart failure screening has been proposed in recent guidelines. However, an effective strategy to identify screening targets from the general population, more than half of which are at risk for heart failure or pre ...
Yuichiro Mori +5 more
doaj +3 more sources
N‐terminal pro brain natriuretic peptide reference values in community‐dwelling older adults [PDF]
Aims Available upper reference levels (URLs) in older adults for N‐terminal pro brain natriuretic peptide (NT‐proBNP), an established biomarker for heart failure, are mainly based on small samples. We aimed to identify NT‐proBNP URL in a population‐based
Ulrike Braisch +8 more
doaj +2 more sources
Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients [PDF]
N terminal pro brain natriuretic peptide (NT‐proBNP) plays an important role in the diagnosis and prognosis of heart failure (HF). The plasma level of NT‐proBNP in atrial fibrillation (AF) patients was higher than of sinus rhythm patients.
Entezar Nasab Mehrabi +2 more
doaj +2 more sources
Diagnostic yield of a heart failure referral pathway using N-terminal pro-brain natriuretic peptide [PDF]
Objective To determine the diagnostic yield of a ‘high’ N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with suspected heart failure (HF) referred from primary to secondary care.Methods In this retrospective study, cardiac diagnoses were
Tamara Naneishvili +9 more
doaj +2 more sources
N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
NT-proBNP is produced from both atria and ventricles. The primary regulation of production is at the synthesis level. The plasma half-life of NT-proBNP is 60-120 min.
Jayachandran Thejus, Johnson Francis
doaj +2 more sources
Assessment of the impact of different N terminal pro brain natriuretic peptide thresholds on echocardiography services [PDF]
Aims N terminal pro brain natriuretic peptide (NT‐proBNP) is considered a rule‐out test for patients with suspected heart failure. The NT‐proBNP thresholds recommended for echocardiography by the European Society of Cardiology (ESC) and National ...
Eric Yii +3 more
doaj +2 more sources
Kadar N-Terminal Pro-Brain Natriuretic Peptide sebagai Prediktor Luaran Klinis Sindrom Koroner Akut [PDF]
Plasma levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) levels may reflect the severity of ischemia, although there is no necrosis. A transient ischemia which can increase the heart wall stretch would induces BNP synthesis and release ...
Florencia Idajanti Tandhana +3 more
doaj +2 more sources
Comparison of Pleural Fluid N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic-32 Peptide Levels [PDF]
Current evidence indicates that measurement of pleural fluid N-terminal pro-brain natriuretic peptide (NT-proBNP) levels can aid in distinguishing pleural effusions of cardiac origin from those of noncardiac origin. To date, only one study, to our knowledge, has described simultaneous measurement of pleural fluid brain natriuretic-32 peptide (BNP) and ...
Ann C. Long +4 more
openalex +4 more sources
Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease [PDF]
PurposeRecent reports showed that plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) could be a useful biomarker of intravenous immunoglobulin (IVIG) unresponsiveness and coronary artery lesion (CAL) development in Kawasaki disease (KD).
Heul Jun +5 more
doaj +3 more sources

